is facing allegations of hijacking technology from two smaller biotech firms to produce its vaccine.The Cambridge, Massachusetts-based company is facing a lawsuit from Arbutus Biopharma and Genevant Sciences, both based in Vancouver, , over allegations that is used lipid nanoparticle technology that infringed on the Canadian companies' patents.Moderna's shot is the second most commonly used in the U.S., and has been a financial success for the previously low-profile biotech brand.
Load More
Load More